Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
07/05/2012 | CA2824630A1 Method for utilizing monoterpene glycosyltransferase |
07/05/2012 | CA2823291A1 Antipyretic/analgesic composition |
07/05/2012 | CA2823182A1 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof |
07/05/2012 | CA2823148A1 Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
07/05/2012 | CA2823066A1 Compositions comprising natriuretic peptides and methods of use thereof |
07/05/2012 | CA2822995A1 Cellular hydration compositions containing cyclodextrins |
07/05/2012 | CA2822859A1 Pharmaceutical formulation comprising a biopharmaceutical drug |
07/05/2012 | CA2822854A1 Biodegradable drug delivery compositions |
07/05/2012 | CA2822853A1 Topical localized isoxazoline formulation comprising glycofurol |
07/05/2012 | CA2822839A1 Topical localized isoxazoline formulation |
07/05/2012 | CA2822176A1 Small molecule conjugates for intracellular delivery of biologically active compounds |
07/05/2012 | CA2822161A1 Small molecule conjugates for intracellular delivery of nucleic acids |
07/05/2012 | CA2816041A1 In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |
07/04/2012 | EP2471819A2 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof |
07/04/2012 | EP2471812A1 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
07/04/2012 | EP2471555A2 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
07/04/2012 | EP2471554A1 Pharmaceutical formulation comprising a biopharmaceutical drug |
07/04/2012 | EP2471539A1 Transdermal composition of phosphatidylcholine and method for producing same |
07/04/2012 | EP2471517A2 Rhein or diacerein compositions |
07/04/2012 | EP2471516A2 Rhein or diacerein compositions |
07/04/2012 | EP2471515A2 Rhein or diacerein compositions |
07/04/2012 | EP2471511A1 Liposome formulation suitable for treating or preventing tuberculosis |
07/04/2012 | EP2471510A1 Liquid formulation of G-CSF |
07/04/2012 | EP2470564A1 Compositions and methods for treating aspergillosis |
07/04/2012 | EP2470257A2 Bone implants for the treatment of infection |
07/04/2012 | EP2470223A2 Sprayable polymers as adhesion barriers |
07/04/2012 | EP2470216A1 Peptide clearing agents |
07/04/2012 | EP2470215A2 Bisphosphonate-prodrugs |
07/04/2012 | EP2470198A2 Glucagon-like peptide-1 receptor (glp-1r) agonists for treating autoimmune disorders |
07/04/2012 | EP2470190A1 Echinocandin derivatives |
07/04/2012 | EP2470186A2 Synthesis and isolation of dendrimer systems |
07/04/2012 | EP2470178A1 Antimycotic pharmaceutical composition |
07/04/2012 | EP2470172A1 Pharmaceutical formulations and methods of use |
07/04/2012 | EP2470165A1 Film coating composition from solid powder compounds |
07/04/2012 | EP2470163A2 Methods and compositions for delivering interleukin-1 receptor antagonist |
07/04/2012 | EP2285416B1 Conjugates for the treatment of mesothelioma |
07/04/2012 | EP2254952B1 Pharmaceutical dye extracted from cranberry with high proanthocyanidin a concentration |
07/04/2012 | EP1883699B1 Non-viral vector system for transporting nucleic acid into the lungs |
07/04/2012 | EP1697398B1 Aqueous suspensions of ciclesonide for nebulisation |
07/04/2012 | EP1624869B1 Dosage form containing pantoprazole as active ingredient |
07/04/2012 | EP1485094B1 Dosage form for oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester or its salts |
07/04/2012 | EP1439858B1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
07/04/2012 | EP1051174B2 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations |
07/04/2012 | DE212011100034U1 Material zur Behandlung von inneren Hohlräumen Material for the treatment of internal cavities |
07/04/2012 | CN1680443B Recombinat protein containing albumin multimer |
07/04/2012 | CN1536986B Intravaginal drug delivery devices for administration of antimicrobial agent |
07/04/2012 | CN1338939B Compositions for the treatment of male erectile dysfunction |
07/04/2012 | CN102549029A Pellets coated with coatings containing active substances |
07/04/2012 | CN102548618A Composition, use, and preservation method |
07/04/2012 | CN102548583A Prodrugs comprising an insulin linker conjugate |
07/04/2012 | CN102548582A Eye drops |
07/04/2012 | CN102548581A Adhesive complex coacervates and methods of making and using thereof |
07/04/2012 | CN102548580A Solutions comprising polyethylene glycol and electrolytes |
07/04/2012 | CN102548575A Eye drops |
07/04/2012 | CN102548562A Ophthalmic composition |
07/04/2012 | CN102548561A Ethyleneoxide butyleneoxide block copolymer compositions |
07/04/2012 | CN102548556A Tablet |
07/04/2012 | CN102548544A Pharmaceutical composition with both immediate and extended release characteristics |
07/04/2012 | CN102548543A Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
07/04/2012 | CN102548542A Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles |
07/04/2012 | CN102548541A Floating microgranules |
07/04/2012 | CN102548540A Solid pharmaceutical preparations comprising amphiphilic copolymers on the basis of polyethers in combination with surfactants |
07/04/2012 | CN102548532A Novel powdered polymer, preparation method thereof and use of same as a thickener |
07/04/2012 | CN102533910A Methods for expression and purification of immunotoxins |
07/04/2012 | CN102533702A Antidotes for factor XA inhibitors and methods of using the same |
07/04/2012 | CN102533655A CHO-S cell strain for efficient expression type human recombinant protein GLP1/Fc and establishment method thereof |
07/04/2012 | CN102532901A Method for preparing simethicone |
07/04/2012 | CN102532580A Method for preparing multifunctional nano-carrier |
07/04/2012 | CN102532569A Preparation method of yak milk casein edible film |
07/04/2012 | CN102532564A Hydrogel and preparation method thereof |
07/04/2012 | CN102532533A Poly(aspartic acid-co-lactic acid)-phosphatidyl ethanolamine graft polymer and preparation method and application thereof |
07/04/2012 | CN102532531A Polyamino acid block copolymer and preparation method thereof |
07/04/2012 | CN102532342A Crude polysaccharide extract of mokara root and application |
07/04/2012 | CN102532326A Tumor-targeted plasminogen Kringle5 variant and application thereof |
07/04/2012 | CN102532303A Synthesis and application of exenatide joined with polyethylene glycol |
07/04/2012 | CN102532300A Interferon alpha mutant and polyethylene glycol derivative thereof |
07/04/2012 | CN102532299A Interferon alpha mutant and polyethylene glycol derivative thereof |
07/04/2012 | CN102532264A Peptide-based compounds |
07/04/2012 | CN102532263A Bi-component drug micromolecule hydrogel based on hexadecadrol and taxol and preparation method thereof |
07/04/2012 | CN102532262A Preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity |
07/04/2012 | CN102532259A Oligopeptide-based cationic lipid derivative and application thereof in pharmaceutical preparation |
07/04/2012 | CN102532199A Structure and synthesis of novel benzyl amido phosphate prodrug of nucleoside compound |
07/04/2012 | CN102526759A Dendritic-polymer-based high-bioavailability oral puerarin preparation |
07/04/2012 | CN102526758A Stable aqueous solution of pegylation interferon |
07/04/2012 | CN102526757A Stable aqueous solution of pegylation interferon |
07/04/2012 | CN102526756A Adriamycin composite, micelle and preparation method for micelle |
07/04/2012 | CN102526755A Reducibly biodegradable release controlled camptothecin nano micelle pre-medicament and preparation method |
07/04/2012 | CN102526754A Application of gum extracted from Abelmoschus manihot as matrix of Chinese medicinal gel |
07/04/2012 | CN102526753A In-situ phase change gel slow release system taking phospholipid as substrate and preparation method thereof |
07/04/2012 | CN102526752A Bitterness-eliminated medicinal preparation |
07/04/2012 | CN102526751A Heat-resistant freeze-dried protective agent for swine fever spleen and lymph tissue origin live vaccine and preparation method for heat-resistant freeze-dried protective agent |
07/04/2012 | CN102526750A Plant colonic-coated hollow capsule |
07/04/2012 | CN102526749A Pharmaceutical composition comprising porous dry matrix |
07/04/2012 | CN102526748A Oral tablet containing valsartan, hydrochlorothiazide and amlodipine besylate |
07/04/2012 | CN102526747A Preparation method and application of starch-based tablet controlled release carrier |
07/04/2012 | CN102526746A Preparation method of enteric type aqueous dispersion coating material |
07/04/2012 | CN102526745A Slow-release method for controlling medicine-carrying molecules of lyotopic liquid crystal by using micro electric field |
07/04/2012 | CN102526744A Medicinal composition and preparation method and application thereof |
07/04/2012 | CN102526743A Coating material for complex tablets and preparation method thereof |
07/04/2012 | CN102526742A Functional nano-carrier with escape capability of lysosome and preparation method of same |